A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2 (original) (raw)

Abbreviations

CNS:

central nervous sytem

FISH:

fluorescent in situ hybridization

LUHMES:

Lund Human Mesencephalic neurons

IMSS:

inner membrane sorting signal

MLS:

mitochondrial localization signal

MOMP:

mitochondrial outer membrane permeabilization. NCI, National Cancer Institute

NLS:

nuclear localization signal

TEM:

transmission electron microscopy

References

  1. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441–446.
    Article CAS Google Scholar
  2. Mate MJ, Ortiz-Lombardia M, Boitel B, Haouz A, Tello D, Susin SA et al. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Biol 2002; 9: 442–446.
    Article CAS Google Scholar
  3. Ye H, Cande C, Stephanou NC, Jiang S, Gurbuxani S, Larochette N et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 2002; 9: 680–684.
    Article CAS Google Scholar
  4. Modjtahedi N, Giordanetto F, Madeo F, Kroemer G . Apoptosis-inducing factor: vital and lethal. Trends Cell Biol 2006; 16: 264–272.
    Article CAS Google Scholar
  5. Joza N, Pospisilik JA, Hangen E, Hanada T, Modjtahedi N, Penninger J et al. AIF: not just an apoptosis-inducing factor. Ann NY Acad Sci 2009; 1171: 2–11.
    Article CAS Google Scholar
  6. Otera H, Ohsakaya S, Nagaura Z, Ishihara N, Mihara K . Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J 2005; 24: 1375–1386.
    Article CAS Google Scholar
  7. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001; 276: 16391–16398.
    Article CAS Google Scholar
  8. Vahsen N, Cande C, Briere JJ, Benit P, Joza N, Larochette N et al. AIF deficiency compromises oxidative phosphorylation. EMBO J 2004; 23: 4679–4689.
    Article CAS Google Scholar
  9. Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002; 419: 367–374.
    Article CAS Google Scholar
  10. Joza N, Oudit GY, Brown D, Benit P, Kassiri Z, Vahsen N et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 2005; 25: 10261–10272.
    Article CAS Google Scholar
  11. Cheung EC, Joza N, Steenaart NA, McClellan KA, Neuspiel M, McNamara S et al. Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J 2006; 25: 4061–4073.
    Article CAS Google Scholar
  12. Ishimura R, Martin GR, Ackerman SL . Loss of apoptosis-inducing factor results in cell-type-specific neurogenesis defects. J Neurosci 2008; 28: 4938–4948.
    Article CAS Google Scholar
  13. van Empel VP, Bertrand AT, van der Nagel R, Kostin S, Doevendans PA, Crijns HJ et al. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 2005; 96: e92–e101.
    Article CAS Google Scholar
  14. Benit P, Goncalves S, Dassa EP, Briere JJ, Rustin P . The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS ONE 2008; 3: e3208.
    Article Google Scholar
  15. Vahsen N, Cande C, Dupaigne P, Giordanetto F, Kroemer RT, Herker E et al. Physical interaction of apoptosis-inducing factor with DNA and RNA. Oncogene 2006; 25: 1763–1774.
    Article CAS Google Scholar
  16. Cande C, Vahsen N, Kouranti I, Schmitt E, Daugas E, Spahr C et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 2004; 23: 1514–1521.
    Article CAS Google Scholar
  17. Gogvadze V, Orrenius S, Zhivotovsky B . Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim Biophys Acta 2006; 1757: 639–647.
    Article CAS Google Scholar
  18. Norberg E, Gogvadze V, Ott M, Horn M, Uhlen P, Orrenius S et al. An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ 2008; 15: 1857–1864.
    Article CAS Google Scholar
  19. Gurbuxani S, Schmitt E, Cande C, Parcellier A, Hammann A, Daugas E et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene 2003; 22: 6669–6678.
    Article CAS Google Scholar
  20. Zhu C, Wang X, Deinum J, Huang Z, Gao J, Modjtahedi N et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 2007; 204: 1741–1748.
    Article CAS Google Scholar
  21. Galluzzi L, Blomgren K, Kroemer G . Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 2009; 10: 481–494.
    Article CAS Google Scholar
  22. Schulthess FT, Katz S, Ardestani A, Kawahira H, Georgia S, Bosco D et al. Deletion of the mitochondrial flavoprotein apoptosis inducing factor (AIF) induces beta-cell apoptosis and impairs beta-cell mass. PLoS ONE 2009; 4: e4394.
    Article Google Scholar
  23. Loeffler M, Daugas E, Susin SA, Zamzami N, Metivier D, Nieminen AL et al. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 2001; 15: 758–767.
    Article CAS Google Scholar
  24. Delettre C, Yuste VJ, Moubarak RS, Bras M, Lesbordes-Brion JC, Petres S et al. AIFsh, a novel apoptosis-inducing factor (AIF) pro-apoptotic isoform with potential pathological relevance in human cancer. J Biol Chem 2006; 281: 6413–6427.
    Article CAS Google Scholar
  25. Delettre C, Yuste VJ, Moubarak RS, Bras M, Robert N, Susin SA . Identification and characterization of AIFsh2, a mitochondrial apoptosis-inducing factor (AIF) isoform with NADH oxidase activity. J Biol Chem 2006; 281: 18507–18518.
    Article CAS Google Scholar
  26. Urbano A, Lakshmanan U, Choo PH, Kwan JC, Ng PY, Guo K et al. AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. EMBO J 2005; 24: 2815–2826.
    Article CAS Google Scholar
  27. Churbanova IY, Sevrioukova IF . Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor. J Biol Chem 2008; 283: 5622–5631.
    Article CAS Google Scholar
  28. Sevrioukova IF . Redox-linked conformational dynamics in apoptosis-inducing factor. J Mol Biol 2009; 390: 924–938.
    Article CAS Google Scholar
  29. Yuste VJ, Moubarak RS, Delettre C, Bras M, Sancho P, Robert N et al. Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release. Cell Death Differ 2005; 12: 1445–1448.
    Article CAS Google Scholar
  30. Cozzolino M, Ferraro E, Ferri A, Rigamonti D, Quondamatteo F, Ding H et al. Apoptosome inactivation rescues proneural and neural cells from neurodegeneration. Cell Death Differ 2004; 11: 1179–1191.
    Article CAS Google Scholar
  31. Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P et al. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 2005; 25: 6329–6342.
    Article CAS Google Scholar
  32. Benit P, Goncalves S, Philippe Dassa E, Briere JJ, Martin G, Rustin P . Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin Chim Acta 2006; 374: 81–86.
    Article CAS Google Scholar
  33. Luft JH . Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 1961; 9: 409–414.
    Article CAS Google Scholar

Download references

Acknowledgements

EH is supported by a fellowship from the Ligue Nationale contre le Cancer. GK is supported by grants from European Union (projects Apo-Sys, ChemoRes, Death-Train), La Ligue Nationale Contre le Cancer (équipe labélisée), Institut National du Cancer (INCa), Agence Nationale de Recherche (ANR). FC is supported by grants from the Telethon Foundation, AIRC and the Italian Ministry of University and Research. PB and PR are supported by grants from European Union (project EumitoCombat), Leducq foundation. GH is supported by the German National Genome Research Network (01GS08136-4). We acknowledge the DTP at NCI for providing RNA samples for NCI60 panel of cancer cell lines; Marcel Leist, University of Konstanz, Germany for providing the LUHMES cells; Abdelali Jalil, Didier Métivier and Fulvio Florenzano for help with flow cytometry and confocal microscopy; Eric Jacquet and Imagif (CNRS) Platform for quantitative RT-PCR analyses.

Author information

Author notes

  1. G Kroemer and N Modjtahedi: These authors share co-senior authorship.

Authors and Affiliations

  1. INSERM U848, Villejuif, France
    E Hangen, F Caffin, S Lachkar, J-L Perfettini, J M Vicencio, G Kroemer & N Modjtahedi
  2. Institut Gustave Roussy, Villejuif, France
    E Hangen, P Dessen, F Caffin, S Lachkar, J-L Perfettini, V Lazar, J Benard, J M Vicencio, G Kroemer & N Modjtahedi
  3. University Paris 11, Orsay, France
    E Hangen, P Dessen, F Caffin, S Lachkar, J-L Perfettini, V Lazar, J Benard, J M Vicencio, G Kroemer & N Modjtahedi
  4. Department of Biology, Dulbecco Telethon Institute, University of Rome, ‘Tor Vergata’, Rome, Italy
    D De Zio, M Bordi & F Cecconi
  5. Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, Rome, Italy
    D De Zio, M Bordi & F Cecconi
  6. Center for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
    C Zhu & K Blomgren
  7. CNRS FRE2939, Vilejuif, France
    P Dessen
  8. Functional Genomic Unit, Villejuif, France
    V Lazar
  9. CNRS UMR8126, Villejuif, France
    J Benard
  10. National Institute for Infectious Diseases, ‘Lazzaro Spallanzani’, Rome, Italy
    G M Fimia & M Piacentini
  11. Laboratoire ‘Réplication de l′ADN et Ultrastructure du Noyau’ CNRS-Institut André Lwoff, Villejuif, 94801, France
    F Harper & G Pierron
  12. INSERM U676, Paris, France
    P Bénit & P Rustin
  13. Hôpital Robert Debré, Paris, France
    P Bénit & P Rustin
  14. University René Diderot, Paris, France
    P Bénit & P Rustin
  15. Experimental Neurology, Philipps University, Marburg, Germany
    A de Andrade & G Höglinger
  16. Department of Pharmacy, Institute for Pharmacology and Toxicology, Philipps-University Marburg, Marburg, Germany
    C Culmsee
  17. Department of Pediatric Oncology, Queen Silvia Children's Hospital, Gothenburg, Sweden
    K Blomgren

Authors

  1. E Hangen
  2. D De Zio
  3. M Bordi
  4. C Zhu
  5. P Dessen
  6. F Caffin
  7. S Lachkar
  8. J-L Perfettini
  9. V Lazar
  10. J Benard
  11. G M Fimia
  12. M Piacentini
  13. F Harper
  14. G Pierron
  15. J M Vicencio
  16. P Bénit
  17. A de Andrade
  18. G Höglinger
  19. C Culmsee
  20. P Rustin
  21. K Blomgren
  22. F Cecconi
  23. G Kroemer
  24. N Modjtahedi

Corresponding authors

Correspondence toG Kroemer or N Modjtahedi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Edited by JC Martinou

Supplementary Information accompanies the paper on Cell Death and Differentiation website

Supplementary information

Rights and permissions

About this article

Cite this article

Hangen, E., De Zio, D., Bordi, M. et al. A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2.Cell Death Differ 17, 1155–1166 (2010). https://doi.org/10.1038/cdd.2009.211

Download citation

Keywords